Clinical Trials Browser

Interventional × Fallopian Tube Neoplasms × sapanisertib × Clear all

NCT02142803 2025-11-13

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Phase 1 Active not recruiting

50 enrolled 16 charts

Fallopian Tube Neoplasms, Glioblastoma, Ovarian Neoplasms

NCT03648489 2024-09-20

DICE

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms